Peer-to-Peer Intervention for Substance Use Disorders
(P2P Trial)
Trial Summary
What is the purpose of this trial?
This study provides substance use and mental health peer support services to address behavioral health disparities in rural areas. Specifically, the project aims to address persistent mental health symptoms, such as anxiety and depression, that become barriers to care for patients working towards long-term recovery from co-occurring mental health and substance use disorders. Participants will be assessed and evaluated for opioid use disorder (OUD), social determinants of health (SDoH), and infectious diseases by a nurse practitioner and a social worker. A certified peer support specialist (CPSS) will provide additional support, connecting patients to sustainable mental health resources and implementing a modified version of the Friendship Bench intervention, which involves six weekly 45-minute problem-solving therapy sessions with the option to participate in six or more peer support sessions. The CPSS will follow the patient for up to 12 weeks.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, since participants must be receiving medication for opioid use disorder (MOUD) for at least 3 months, it seems you will need to continue that treatment.
What data supports the effectiveness of the P2P Intervention treatment for substance use disorders?
Is the Peer-to-Peer Intervention for Substance Use Disorders safe for humans?
How is the P2P Intervention treatment for substance use disorders different from other treatments?
The P2P Intervention is unique because it involves peer support, where individuals with personal experience in overcoming substance use disorders help others going through similar challenges. This approach can reduce stigma, improve treatment satisfaction, and increase retention by providing relatable support and mentorship, which is different from traditional treatments that may not include peer involvement.2791011
Research Team
Alain Litwin
Principal Investigator
Prisma Health
Eligibility Criteria
This trial is for individuals with substance use disorders who are facing mental health challenges like anxiety and depression, particularly in rural areas. Participants should be dealing with co-occurring mental health and substance abuse issues, and will be evaluated for opioid use disorder, social factors affecting health, and infectious diseases.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a modified version of the Friendship Bench intervention, involving six weekly 45-minute problem-solving therapy sessions and optional peer support sessions
Follow-up
Participants are monitored for reduction in depressive symptoms and other outcomes
Treatment Details
Interventions
- P2P Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Prisma Health-Upstate
Lead Sponsor
South Carolina Center for Rural and Primary Healthcare
Collaborator